Enhancing Juvenile Drug Court Outcomes With Evidence-Based Practices
|ClinicalTrials.gov Identifier: NCT01266109|
Recruitment Status : Completed
First Posted : December 24, 2010
Last Update Posted : June 18, 2013
Juvenile drug courts were developed in response to a perceived need to intervene more effectively with youth with substance abuse problems. Close collaboration between the court and substance abuse treatment provider is a defining component of the drug court model and is critical to helping youth achieve positive outcomes. Despite the proliferation of juvenile drug courts in recent years, however, evaluation of their capacity to reduce offender substance use and criminal activity has lagged. Moreover, the Institute of Medicine (IOM, 1998) and leading experts (McLellan, Carise, & Kleber, 2003) have presented a bleak picture of the nation's capacity to meet the treatment needs of substance abusing individuals. Although community-based programs provide the backbone of substance abuse treatment in the nation, their capabilities have not kept up with major scientific advances in the development and validation of evidence-based substance abuse interventions.
Building on our research findings and experience regarding juvenile drug court outcomes as well as the transport of evidence-based practices to community treatment settings, the purpose of this study is to develop and test a relatively flexible and low cost strategy for enhancing the outcomes of juvenile drug courts by integrating components of evidence-based treatments into existing substance abuse services.
Specifically, this project aims to:
Aim 1: Adapt existing intervention and training protocols from evidence-based practices (i.e., Contingency Management for adolescent substance abuse; family engagement strategies from evidence-based treatments of juvenile offenders) for integration into juvenile drug court sites.
Aim 2: Conduct a study to examine youth (e.g., substance use and criminal behavior) and system level (e.g., intervention adherence, feasibility, retention and completion rates, consumer satisfaction, cost estimates) effects of implementing the intervention protocols in juvenile drug courts.
Aim 3: Revise the intervention and training protocols in preparation for a Stage II study if findings are supportive.
|Condition or disease||Intervention/treatment||Phase|
|Adolescent Substance Use||Behavioral: Contingency Management-Family Engagement (CM-FAM) Other: Usual Services (US)||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||172 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Enhancing Juvenile Drug Court Outcomes With Evidence-Based Practices|
|Study Start Date :||September 2007|
|Actual Primary Completion Date :||March 2012|
|Actual Study Completion Date :||March 2012|
Behavioral: Contingency Management-Family Engagement (CM-FAM)
Evidence-based outpatient intervention for adolescent substance use
|Active Comparator: US||
Other: Usual Services (US)
Typical community-based substance abuse treatment services
- Substance Use [ Time Frame: Quarterly for up to 1 year post-baseline ]
- Delinquency [ Time Frame: Quarterly for up to 1 year post-baseline ]
- Intervention Fidelity [ Time Frame: Monthly for up to 1 year post-baseline ]
- Cost Estimates [ Time Frame: Annually for 4 years ]
- Consumer Satisfaction [ Time Frame: Bi-annually for 4 years ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01266109
|United States, South Carolina|
|Medical University of South Carolina|
|Charleston, South Carolina, United States, 29425|
|Principal Investigator:||Scott W Henggeler, Ph.D.||Medical University of South Carolina|